Before arriving at the moon, the small satellite mission will use the gravity of the sun, Earth, and moon over several months ...
Egypt-based computer numerical control (CNC) machine manufacturer Simplex has secured US$13 million in funding through a ...
This Press Release updates numerical list in reference sectionTheralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of th ...
This Press Release updates numerical list in reference section Theralase® validates previous University of Manitoba research ...
Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ACCES ...
Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the ...
WOBURN, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...
Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...
University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection.